Impact of timing to initiate adjuvant therapy on survival of elderly glioblastoma patients using the SEER-Medicare and national cancer databases

The optimal time to initiate adjuvant therapy (AT) in elderly patients with glioblastoma (GBM) remains unclear. We investigated the impact of timing to start AT on overall survival (OS) using two national-scale datasets covering elderly GBM populations in the United States. A total of 3159 and 8161...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ping, Du, Xianglin L., Hwang, Lu-yu, Lairson, David, Li, Ruosha, Esquenazi, Yoshua, Zhu, Jay-Jiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968296/
https://www.ncbi.nlm.nih.gov/pubmed/36841851
http://dx.doi.org/10.1038/s41598-023-30017-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968296/
https://www.ncbi.nlm.nih.gov/pubmed/36841851
http://dx.doi.org/10.1038/s41598-023-30017-z

Ejemplares similares